PROPEL

Decoding How Sponsors Evaluate Research Sites for Clinical Trials

April 17, 2024 by

When selecting clinical research sites for their trials, sponsors look for a blend of capabilities, resources, and a proven track record that promises the best outcomes for their studies. With sponsors seeking top-performing sites that align with their trial objectives, the ability to showcase expertise, efficiency, and reliability is key component of successful to success. This selection process is crucial as the chosen sites directly impact the efficiency, compliance, and ultimately the success of the clinical trials.  

In this blog, we’ll explore the key factors that sponsors consider when evaluating potential clinical research sites. From the expertise of the staff and the facility’s infrastructure to patient recruitment strategies and regulatory compliance, understanding what sponsors are looking for can help clinical sites not only meet but exceed these expectations. Whether you’re a seasoned investigator or a site looking to attract more trials, this insight into sponsor priorities will provide valuable guidance on how clinical research sites can use purpose-built technology, like PROPEL, built by Devana Solutions, to demonstrate that they are a high-performing site that stands out in a competitive field. 

Site Experience and Expertise 

One of the primary considerations for sponsors during site selection is experience and expertise. Sponsors prefer sites with a proven track record of successfully conducting similar trials, demonstrated by a history of patient recruitment, retention, and data quality. Additionally, sites and Physician Investigators (PIs) having expertise in specific therapeutic areas or specialized procedures relevant to the trial protocol is also highly valued.   

By centralizing data management, PROPEL is a pioneering platform that enables sites to efficiently track and report on key performance metrics. This consolidation of data within a single system streamlines operations, offering unprecedented visibility into trial progress and site performance. With its powerful analytics and reporting capabilities, PROPEL enables research sites to transparently showcase their past and current performance metrics to sponsors. From patient recruitment statistics in a given indication to site activation timelines, PROPEL generates customizable reports highlighting a site’s efficiency and effectiveness.  With PROPEL, sites can effectively monitor their performance, identify areas for improvement, and demonstrate their capabilities to sponsors with unparalleled precision and efficiency. Sponsors appreciate sites that can provide transparent and timely performance data, as it allows them to make informed decisions when selecting partners for their trials. Moreover, this transparency enhances the site’s reputation and ultimately strengthens the overall partnership between sites and sponsors. 

Patient Population and Recruitment Potential 

Patient retention and recruitment is another pivotal factor for success in clinical trials. Access to diverse patient pools is particularly important. Clinical research sites are assessed by sponsors based on their access to the target patient population and their innovative strategies for patient recruitment. Sponsors assess clinical research sites based on their access to the target patient population and their strategies for patient recruitment.   

In recent years, there has been a growing mandate to improve diversity in clinical trial populations. This push is driven by the recognition that diverse populations may respond differently to treatments, which has significant implications for the generalizability of trial results. In fact, regulatory bodies like the FDA in the United States have issued guidelines that encourage the inclusion of varied demographic groups in clinical trials to ensure that the findings are applicable to a broader population. These guidelines recommend that trial designs consider factors such as age, gender, and racial and ethnic backgrounds. Sites that have established relationships with patient communities often have an advantage. These relationships facilitate trust and communication, which are crucial for encouraging participation and ensuring participants remain engaged throughout the trial.   

Sponsors value sites that can leverage past and real-time data analytics to drive continuous improvement and ensure the success of their trials. PROPEL’s advanced analytics capabilities provide clinical research sites with invaluable insights into trial performance. By analyzing site metrics, patient recruitment trends, and operational efficiency indicators, sites can make data-driven decisions that optimize trial strategies and resource allocation. Additionally, sites can track which patient recruitment methods have worked the best in the past to inform future decisions. Plus, PROPEL’s seamless integrations with the leading CTMS providers allows for a full-cycle view of past trial performance and patient recruitment.  

Site Facility and Resources 

The physical infrastructure and resources available at a site are carefully evaluated by sponsors. This includes the availability of state-of-the-art facilities for patient visits, laboratory capabilities for sample processing, and access to necessary equipment and technology. Adequate staffing, including trained research personnel and support staff, is essential for efficient trial conduct.  

Using comprehensive site profiles, PROPEL makes it easy to see all the key capabilities, equipment, and staff members in one place. For larger site networks, PROPEL enables central teams to query all their sites and filter by specific criteria, including equipment and therapeutic specialties. This makes it easy for research site organizations of all sizes to respond quickly to sponsors about how their available resources match up to the trial opportunity.

Regulatory Compliance and Quality Assurance 

Sponsors are increasingly vigilant about regulatory compliance, given its impact on the integrity and validity of trial results. Sites that can demonstrate that they prioritize and manage regulatory aspects effectively are often more attractive to sponsors. This includes compliance with Good Clinical Practice (GCP) guidelines, adherence to protocol requirements, and timely reporting of adverse events. Sites with robust quality assurance processes and a culture of continuous improvement tend to be favored by sponsors.  

PROPEL simplifies regulatory compliance for sites, offering a comprehensive platform for tracking all necessary regulatory documents. The platform includes automated compliance workflows, which significantly reduces the potential for human error and improves the efficiency of compliance processes. Furthermore, PROPEL provides detailed audit trails for sites to consistently verify and document their compliance status throughout the clinical trial process. Altogether, PROPEL helps sites demonstrate their commitment to maintaining high-quality standards. 

Budget and Contract Negotiation 

While not the sole determining factor, budget considerations play another significant role in site selection. Sponsors evaluate potential sites based on their proposed budgets, which include personnel costs, overhead expenses, and any additional services required. Additionally, a site’s negotiation skills and their ability to offer flexible contract terms can also influence site selection decisions.  

PROPEL further optimizes trial management by centralizing tasks and automating many routine workflows, thereby improving efficiency, reducing the administrative burden, saving time and money, and minimizing errors. The platform’s ability to capture real-time data allows research sites to document these efficiencies and cost savings through detailed reports and key performance indicators (KPIs). This capability helps sites distinguish themselves in a competitive field.  Sponsors are drawn to sites that can demonstrate streamlined operations, as it signifies a commitment to excellence and a focus on delivering high-quality data within stipulated timelines. 

Communication and Collaboration 

Effective communication and collaboration between sponsors and clinical research sites are essential for the smooth conduct of clinical trials. Sponsors further evaluate sites based on their responsiveness, transparency, and willingness to collaborate on trial-related activities. Sites that demonstrate proactive communication and a commitment to addressing sponsor concerns are more likely to be selected as effective collaboration is a cornerstone of successful clinical trials.   

PROPEL is purpose-built to facilitate seamless communication and collaboration among site teams, sponsors, CROs, and other stakeholders. Real-time sharing of information, progress updates, and feedback fosters a collaborative environment that instills confidence in sponsors. Sites that leverage PROPEL to enhance collaboration and data-sharing are more likely to stand out to sponsors seeking reliable partners. 

Stand Out with PROPEL 

Selecting the right clinical research sites is a critical step in the success of clinical trials. Sponsors carefully evaluate sites based on various factors, including experience, patient recruitment potential, facilities, and more. Devana Solutions’ one-of-a-kind PROPEL platform empowers sites to elevate their performance and stand out to sponsors. By streamlining and automating operations, enhancing collaboration, enabling data-driven decision-making, ensuring regulatory compliance, and providing transparent performance metrics, PROPEL equips sites with the tools they need to showcase their expertise and reliability. As sponsors seek out top performing sites to partner with, PROPEL emerges as a key differentiator that enables research sites to shine and win more trial opportunities from sponsors and CROs.  

Devana Solutions  

A RealTime Software Solutions Company, Devana Solutions is an innovative cloud-based clinical trial software provider that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.   

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.  

Read More: Case Study – Accellacare (ICON’s Global Site Network) & Oncacare (specialized oncology site network) 

PROPEL

Advancing Clinical Trial Site Management: Strategies for Improved Performance

March 20, 2024 by

One common frustration in the initiation phase of clinical trials is the frequent occurrence of delays. In an analysis published by Nature, nearly a quarter of all trials experienced setbacks due to strategic issues, commercial barriers, and operational challenges. The financial repercussions of such setbacks are significant, with drug developers facing potential losses ranging from $600,000 to $8 million per day. While this statistic is commonly seen as the cost of doing business, effective site management empowered by the right technology can help save time and money throughout the life of a clinical trial. 

Devana Solutions’ PROPEL platform provides a cutting-edge solution designed to transform site management and empower central and site-based teams alike with tools for accelerating study startup, improving site turnaround times, and more. PROPEL fosters a strong connection between both teams, allowing for interactions during study startup and beyond, from collaborating on contracts and budgets for a given trial to determining equipment needs for upcoming studies. Based on internal analysis, clients have saved up to 14.25 hours per study activation and a 76% reduced contract and budget turnaround time thanks to PROPEL’s unique streamlined workflows and improved trial management tools. 

Establish Centralized Operations 

It is crucial for clinical research sites to have a central and reliable source of information for all aspects of a clinical trial. From study startup to regulatory document management, PROPEL consolidates critical functions into a single, user-friendly platform and serves as the centralized hub and project management tool for both central and site-based teams.  

PROPEL Trial Record.

With consolidated operations, research organizations can more easily develop standardized processes across all sites and teams – saving time and money. PROPEL’s advanced study startup and project management tools allow trials to progress quickly, with automated alerts keeping everyone on task. PROPEL’s comprehensive site and contact profiles also help with site management and oversight, storing all related documents and information for a given site, investigator, office staff member, vendor, and more. Users are notified of expiring certifications and can easily share updates to keep profiles current. 

But PROPEL doesn’t stop at sites and operations teams – it connects every functional group in the organization, including business development, feasibility, finance, regulatory, leadership, and more, – keeping everyone on the same page using a secure, shared platform. This streamlining of operations enhances efficiency, reduces the risk of errors, and ensures that sites can focus on what matters most – helping patients and advancing clinical trials. 

Boost Collaboration 

Effective and timely collaboration is the heartbeat of successful clinical trials. PROPEL facilitates seamless communication among research sites, central team members, leadership, sponsors, CROs, and other stakeholders. Its integrated features such as threaded chat conversations enable real-time sharing of information, documents, progress updates, and feedback – fostering a collaborative environment that accelerates decision-making and enhances the overall efficiency of individual sites. All correspondence is also logged for future reference and reporting.   

When it comes to selecting a site for a trial, PROPEL allows central teams to query all sites in their network, filter key capabilities and equipment, and send opportunities directly within the platform. Sites are notified upon receiving a new trial opportunity, allowing them to review the specifics, determine the best investigator, and instantly provide feedback to central teams – all using the same system. There’s no need to sift through emails or physical files because all the necessary information is located within PROPEL. As sites respond to opportunities, the system tracks all responses and turnaround timing metrics.  

Once a trial begins, research professionals can quickly share protocols, contracts, and other supporting trial documentation and updates with each other, no matter their location. Both site and central team members can also update milestones as trials progress – speeding study startup and improving visibility across the organization. 

Implement Data-Driven Decision-Making 

PROPEL Site Activity Dashboard.

For leadership teams, PROPEL goes beyond simple data management by offering powerful analytic tools. Organizations can leverage PROPEL’s custom dashboards and reports to gain actionable insights into trends such as patient recruitment, site performance, and more. This empowers central team members to make data-driven decisions on the fly, allowing them to react quickly to changes and new information as they optimize resource allocation, improve recruitment strategies, and enhance overall trial outcomes. 

Final Thoughts 

Standing out to CROs and sponsors is a critical feat for sites looking to grow their business and win more trial opportunities. In general, CROs and sponsors are looking for sites and networks with past experience in a given indication, good patient recruitment and retention rates, and overall quick turnaround times. PROPEL helps sites capture this data automatically as trials progress through the systems and displays it in the form of powerful dashboards and reports, making your data easy to share with both internal and external stakeholders. Quickly see which indications you’ve had the most success in, turnaround timing metrics for site activities, and real-time patient enrollment numbers at any time – all evidence for how well your site could perform on a new trial opportunity, giving you better leverage for winning new studies and negotiating terms.  

PROPEL offers a first-of-its-kind solution to mitigate delays, optimize resource allocation, and accelerate the pace of clinical research. A centralized platform strengthens operational excellence across clinical research site organizations to enhance collaboration and empower data-driven insights. PROPEL provides easy access and visibility into trial and site metrics across your network – helping to bridge data gaps, reduce delays, and ultimately, secure and complete more trial opportunities. 

Devana Solutions  

A RealTime Software Solutions Company, Devana Solutions is an innovative cloud-based clinical trial software provider that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trial systems.   

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.  

PROPEL

Transitioning from Paper to Electronic Workflows in Clinical Trials with PROPEL

February 21, 2024 by

Clinical trials play a pivotal role in advancing medical research and bringing new treatments to patients. Traditionally, trials have been conducted using paper-based methods for startup activities and beyond, such as negotiating Confidentiality Disclosure Agreements (CDAs) and managing regulatory processes, but the landscape is rapidly evolving. In recent years, there has been a growing momentum towards digitizing and modernizing clinical trials overall – including electronic documents.  

Embracing electronic documents and tools such as Devana Solutions’ category-defining PROPEL platform can help increase an organization’s efficiency, accuracy, compliance, and more throughout the entire clinical trial process. PROPEL is a business process improvement platform that touches all things clinical trials – from pipeline management and streamlined study startup through to historical trial metrics – including document management, providing one source of truth for all your clinical trial data that can be easily shared with internal and external shareholders alike.  

Why Transition 

There are many compelling reasons as to why the clinical trials industry should consider moving away from paper and embracing digital solutions, including: 

  1. Efficiency and Speed: One of the primary advantages of transitioning to digital platforms and electronic documents is the significant improvement in efficiency and speed. Paper-based processes are inherently slow and prone to errors, leading to delays in data collection and analysis. PROPEL enables real-time data entry, instant updates, automatic alerts and reminders, and streamlined communication among stakeholders, reducing the overall duration of clinical trials. 
  2. Data Accuracy and Quality: Accuracy and quality of data are paramount in clinical trials. Paper-based methods are susceptible to transcription errors, missing data, and inconsistencies. PROPEL offers built-in validation checks, automated data entry, and centralized databases that enhance the accuracy and integrity of trial data. This not only ensures reliable results but also contributes to more robust regulatory submissions. 
  3. Cost Savings: While there may be initial costs associated with implementing digital solutions, the long-term benefits often outweigh them. PROPEL eliminates the need for paper storage, duplicate data entry, and extensive monitoring efforts, leading to substantial cost savings over the course of a clinical trial. All trial-related data and files are stored in a single, secure place, saving time and money when it comes to making changes, sharing updates, searching for historical information, and more. 
  4. Regulatory Compliance: The regulatory landscape governing clinical trials is evolving, and regulatory agencies are increasingly recognizing the benefits of digital solutions. When progressing trials through the startup process and beyond, PROPEL helps to track all regulatory stages, ensuring research site organizations stay prepared for regulatory expectations, contributing to smoother interactions with health authorities. 
  5. Flexibility and Adaptability: Digital platforms provide the flexibility to adapt to evolving trial requirements and protocol changes. Unlike paper, which can be rigid and difficult to modify, PROPEL allows for quick updates and amendments. This adaptability is crucial in the dynamic landscape of clinical research, where trial protocols may need adjustments based on emerging data or regulatory feedback. 
  6. Scalability: As operations grow and expand, having digitized document management is key. Whether you’re looking to add a new investigator or an entirely new site, onboarding is made faster and easier with agile technology. PROPEL enables users to securely share documents between stakeholders regardless of their physical location, helps establish standardized processes across different locations for improved efficiency, and allows central teams to monitor real-time activities across all sites. 

Make the Leap 

The shift from paper to digital in clinical trials represents a transformative leap towards a more efficient, accurate, and adaptable approach to medical research. While challenges and barriers may exist, the benefits of adopting digital solutions like PROPEL far outweigh the status quo. Embracing the future of clinical trials means embracing technology that can revolutionize the way we bring new therapies to patients, ultimately improving healthcare outcomes for all. 

Devana Solutions  

A RealTime Software Solutions Company, Devana Solutions is an innovative cloud-based clinical trial software provider that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.  

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.  

PROPEL

Why Your Clinical Research Site Needs More Than a CTMS

January 17, 2024 by

Clinical trials require precise management across various domains such as patient recruitment, data collection, regulatory compliance, and stakeholder communication. While Clinical Trial Management Systems (CTMS) have been pivotal in organizing and simplifying many of these aspects for clinical research sites, the complexity of modern clinical research often necessitates a broader array of solutions.  

CTMS platforms are instrumental in managing the logistics of clinical trials. Its primary functions include organizing and tracking study milestones, managing patient recruitment and data, ensuring compliance with regulatory standards, and handling site management and financial aspects of the trials. These systems are crucial for maintaining an organized workflow and ensuring that all trial aspects are conducted according to protocol and within regulatory bounds. However, the landscape of clinical research is continuously evolving, driven by technological advancements, increasing data volumes, and more stringent regulatory requirements. As a result, clinical trials are becoming more complex and diversified, often involving multifaceted data sources, varying patient demographics, and innovative study designs. Accordingly, relying solely on CTMS may fall short of meeting the diverse and expanding needs of modern trials.  

Beyond enrollment and the more limited scope of a CTMS, Devana Solutions’ PROPEL cloud-based platform expands the power of your data and trial administration. From pipeline management and pre-award milestones through to trial completion, PROPEL enables you to standardize, streamline, and automate all of your clinical trial processes. 

Enhanced Data Analytics 

PROPEL indications dashboard

PROPEL Indications Dashboard.

Clinical trials generate vast amounts of data, and leveraging this data effectively can be a game-changer. While a CTMS is proficient at managing enrollment and select operational data, PROPEL adds a layer of advanced analytic capabilities on top. PROPEL’s seamless integrations with the leading CTMS providers eliminate duplicate data entry and offer more robust reporting. See all your data for the entire clinical trial process in one place. From opportunities still in the pipeline to trials in pre- and post-award stages, easily break down your data by trial, site, indication, sponsor, and more – all in real time. 

In combining PROPEL’s analytics with a CTMS, research organizations gain valuable insights into site and overall performance, allowing for data-driven decisions that optimize trial design, recruitment strategies, and resource allocation. Plus, PROPEL’s powerful collaboration features allow you to seamlessly incorporate site feedback and updates into decisions, ultimately improving overall patient experience and trial outcomes. 

Adaptive Trial Management 

In clinical trial management, there is an increasing focus on adaptive trial designs and real-time adjustments. An adaptive design adds flexibility, allowing for certain modifications to be made after a trial is underway. The FDA released guidance on such trial designs in 2019. PROPEL’s agile project management tools and focus on site engagement complement a CTMS by providing a dynamic approach to trial management. With automated study startup workflows, PROPEL allows organizations to standardize and accelerate processes – saving time and money while also providing full visibility into current and next steps.  

Once a trial begins at a site, tracking progress and staying in touch is made easier with PROPEL – allowing both sides to update milestones, share key documents, and respond to questions. As a trial moves through the system, PROPEL captures turnaround timing metrics and performance insights which can be used to identify patterns and make quick adjustments on the fly.  

By integrating PROPEL with a CTMS and empowering sites, research organizations can adapt to emerging challenges, optimize resources, and make informed decisions on site selection and management, ensuring the success of adaptive trial designs. 

Beyond CTMS 

While a CTMS remains an indispensable tool for managing the operational aspects of clinical trials, its potential is maximized when integrated with complementary solutions like PROPEL. Working together, your CTMS and PROPEL provide a holistic view of your entire clinical trial process from start to finish. Manage trials, contacts, documents, and more – all in one place. And PROPEL’s open API also allows you to integrate other tools your team uses such as Outlook, Pardot, and beyond to help manage your customers and win future awards.  

An approach that combines patient-centric technologies, data analytics, regulatory compliance tools, and adaptive trial management systems empowers researchers to navigate the complexities of modern clinical research successfully. By embracing a comprehensive ecosystem of integrated solutions, the clinical trial community can enhance efficiency, improve patient outcomes, and accelerate the development of innovative treatments. 

Devana Solutions  

A RealTime Software Solutions Company, Devana Solutions is an innovative cloud-based clinical trial software provider that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.  

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.  

About Us

2023 Year in Review

December 19, 2023 by

As December winds down, we can officially say that 2023 has been a year of transformative growth and innovation at Devana Solutions! We’ve seen major updates and enhancements in our product offerings, and experienced exciting developments in our business structure. 2023 has been a landmark year, setting new milestones and paving the way for even greater successes to come. 

Products 

This year, we made a dedicated effort to bring several new interface and usability updates across PROPEL and LYNK. Our category-defining software is now more user-friendly and accessible than ever! 

Some of the exciting new features released this year include: 

  • Surveys 
  • Notes 
  • Revenue forecasting 
  • Trial management hub 

 In addition to these new items, we also enhanced several existing features and functions of the platform such as trial tracking, document management, historical enrollment metrics, and more. We plan to continue bringing even more features and refinements to PROPEL and LYNK in the future, so look forward to regular updates throughout 2024. 

Client-Partners 

Customer satisfaction is core to our mission, and we are committed to providing the best-in-class customer experiences. This year, Devana welcomed many new partner-clients to the platform while also experiencing steady growth with existing customers. We are proud to support our partner-clients as they continue to grow and expand their business and site networks across the industry. Such aggressive, sustained growth is only possible with a powerful platform like PROPEL, which provides comprehensive trial management and data analytics for site organizations of all shapes and sizes. We are honored to support them in our shared mission of bringing new and better therapies to patients all over the world.  

Giving Back 

Alongside our continued partnerships with clients, Devana is also pleased to have continued our support of Greater Gift in 2023. As part of their mission to increase awareness of clinical trials and celebrate those who participate in them, Greater Gift works with other non-profit organizations to pay forward the contributions of individuals involved with clinical research to children in need. This year, Devana ramped up our support of Greater Gift with a new process of making a donation for each new client who completes onboarding with PROPEL. With this method, we now support Greater Gift all year long in addition to our annual donation around the holidays honoring of all our current partner-clients. 

Strategic Partnerships 

Last, but certainly not least, we want to highlight our partnership evolution with RealTime Software Solutions. Since Devana’s acquisition by RealTime in July, both companies have been hard at work integrating our teams, products, and services. Our companies are aligned in our commitment to customer service and innovation. We are dedicated to delivering powerful solutions that empower the clinical research industry and further streamline the development of life-changing treatments. We’re thrilled to set a new standard for end-to-end site platforms.  

What Lies Ahead 

As we close the chapter on an extraordinary 2023 and look ahead to 2024, we’re filled with anticipation for the continued evolution of our services, products, and partnerships, all aimed at empowering the clinical research industry. Thank you for being a part of our 2023 journey. Here’s to a new year filled with more milestones, achievements, and shared successes! 

Devana Solutions  

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.  

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.  

About Us | Analytics | Clinical Trials

Devana Solutions CEO Barry Lake on Note to File Podcast

June 1, 2022 by

Devana Solutions CEO Barry Lake recently sat down with Brad Hightower of the Note to File Podcast to discuss the current state of the industry and the importance of sites tracking their own metrics using clinical trial software like Devana Solutions.

Offering holistic trial analysis and a dynamic site and investigator database, Devana Solution’s enterprise software gives businesses the crucial support and data management they need to focus on their own business efforts and core competencies. We understand the unique challenges of the clinical trials industry and offer comprehensive solutions such as automated data evaluation and communication, freeing teams from repetitive tasks so they can focus on winning more study contracts.

For life-saving therapies and vaccines to reach patients more quickly, leading research organizations turn to Devana Solutions for cutting-edge cloud-based SaaS technology and services in the clinical trial industry.

Check out Barry’s episode of the Note to File Podcast here.

Note to File Podcast

Note to File is a podcast for clinical research sites, featuring interviews, best practices, and candid commentary from host Brad Hightower, founder of Hightower Clinical and clinical research professional. The podcast was born with the hope of providing a resource for research professionals to share their stories and serve as a source for practical advice for the clinical research community.

Devana Solutions

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.

PROPEL

Boost Study Contract Wins in the Clinical Trial Industry

April 11, 2022 by

Is your clinical trial organization looking to boost study contract wins and shorten the sales cycle? Then you need to ensure you have the right tools in your tech stack. In the age of technology, there are many options available but one you must include is a trial startup software that synchronizes your communication and data for increased efficiency.

A quality trial startup technology solutions provider, like Devana Solutions, will understand the unique challenges of the industry and offer comprehensive solutions such as automated data evaluation and communication that frees the sales team from repetitive tasks so they can focus on winning the study contract.

Devana Solutions Saves Time and Shortens Sales Cycles

By eliminating repetitive tasks, Devana Solutions’ PROPEL platform is able to shorten the overall sales cycle. Put an end to the tedious work in spreadsheets or disparate systems, as PROPEL is able to automate sales processes, capture a complex chain of emails, and account for customized variations.

In addition, PROPEL allows for each cross-functional team to seamlessly communicate with one another and understand what stage the trial is in during the startup process. The best software will be easily accessible to every decision-maker across the trial management process.

How Trial Software Software Boosts Sales in the Clinical Trial Industry

Increased data means more informed decision-making. With a vibrant and dynamic site and investigator database, as well as up to date performance metrics, the sales team is able to focus their efforts to determine the best trial opportunities for their organization. Increased data streams allow the organization to predict how their business development strategies will affect their overall operations.

Choosing the Best Trial Startup Software for Your Clinical Trial Business

The best clinical trial software will be one that is designed with the unique challenges of the clinical trials industry in mind. Offering holistic trial analysis and a dynamic site and investigator database, Devana Solutions’ PROPEL enterprise software gives businesses the crucial support they need to focus their business efforts for much success.

Sign up for a free demo and learn what makes PROPEL the best in the industry.

Devana Solutions

Devana Solutions is an innovative cloud software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.

Events

2022 World Vaccine Congress: What to Expect

March 29, 2022 by

Devana Solutions executives are attending the 2022 World Vaccine Congress in Washington D.C., on April 18-21, 2022. Here’s what leaders in the biopharma industry can expect.The World Vaccine Congress, in existence for over two decades, has grown to become the largest and most established conference dedicated to vaccines, globally. The World Vaccine Congress 2022 will bring together thousands of industry experts across the entire vaccine landscape, with key sessions dedicated to the fight against COVID-19. Taking place April 18-21 at the flagship hotel, Marriott Marquis Washington, DC, the event will be one of the first opportunities to meet in person since the pandemic began to learn, share experiences and ground-breaking knowledge, and network with others who are working against COVID-19 and on other important vaccines.

“If there is anything that the last two years have taught this industry, it’s that the pandemic has certainly put the focus on the need for cutting-edge research to produce more and better vaccines,” Devana Solutions CEO and Co-Founder Barry Lake.

Inside Peek: 2022 World Vaccine Congress Washington

An event that prides itself on covering every subject across the entire vaccine value chain, here is what to expect if you are attending:

  • Visionary Presenters
  • Engaging Agenda
  • Networking Breaks
  • Vaccine Excellence Awards

Visionary Presenters

This year’s presenters are disruptors and visionary industry leaders from the biopharma industry. They are selected for their relevance, dynamism, and insight. Just a handful of speakers at the World Vaccine Congress include:

Engaging Agenda

From basic research to commercial manufacture, World Vaccine Congress covers the whole vaccine value chain where science, government and manufacturers all come together to create ground-breaking progress. If you are involved in vaccines or new to it because of the pandemic, World Vaccine Congress is the most important meeting you will be part of in 2022.

Here are some of the topics discussed each day:

April 18

  • Biodefense and preparedness
  • Maternal immunization
  • Vaccine Technology
  • Antimicrobial resistance
  • Antibodies in treating COVID and infectious diseases
  • HIV

April 19

  • Plenary Sessions
  • Interactive roundtable discussions
  • Evening drinks & ViE Awards Dinner

April 20 & 21

  • COVID, influenza and other respiratory diseases
  • Immune profiling
  • Cancer immunotherapy
  • One health and veterinary vaccines
  • Clinical trials and development
  • Manufacture
  • Safety
  • Market access
  • Supply & logistics
  • Newly infectious and chronic diseases

Networking

Being the first in-person World Vaccine Congress since 2020, networking is an essential part of the conference experience. You can find new opportunities to collaborate or meet other people in your field. With over 30 scheduled networking events, from coffee breaks to luncheons, there is ample opportunity to learn and network with colleagues across the industry.

Vaccine Excellence Awards

On Tuesday, April 19th, the World Vaccine Congress will be hosting the 15th Annual Vaccine Industry Excellence Awards Ceremony & Dinner. The Scientific Advisory Board members will help make the final decision in each category, and the winners will be announced at the dinner.

“Devana Solutions is proud to have supported many of the leading vaccine research site organizations that stepped up in a big way during the COVID pandemic, including hyperCORE International, Benchmark Research, Centricity Research, Javara Research, Velocity Clinical Research and Accel Research Sites. We wanted to be in Washington, D.C. to support many of these clients nominated for well-deserved Vaccine Excellence Awards,” said Lake.

Are you planning on attending the 2022 World Vaccine Congress Washington? We’d love to chat. Devana Solutions’ CEO and Co-founder Barry Lake and Director, Strategic Partnerships, Emily Hardy, will be attending the show in the nation’s capital and are available to discuss how technology can improve your clinical trial management process. Connect with Barry or Emily on LinkedIn or use the contact form at the bottom of the page to set something up before the big event!

About Us

Devana Solutions Enhances Advisory Board with Addition of Velocity Clinical Research’s Craig Koch

March 17, 2022 by

[Chapel Hill, NC, March 17, 2022] Devana Solutions, the leading cloud SaaS provider to the clinical trials industry to connect centralized research professionals to staff and clinicians at decentralized site locations, announced today that industry veteran Craig Koch has joined Devana’s Advisory Board. Koch is currently Executive Vice President of Velocity Clinical Research, a leading integrated research organization in the U.S. with global expansion now underway. Koch will join current Syneos Health Senior Vice President Tom Wollman and longtime software investor and advisor Reid Conrad currently on Devana’s Advisory Board.

“I am delighted to have Craig join our Advisory Board,” stated Barry Lake, Devana Solutions’ CEO, “Velocity Clinical Research is perhaps the most optimized organization now leveraging our advanced PROPEL enterprise platform, and Craig’s analytical skills and leadership are a big reason why. I look forward to his contributions as an advisor to Devana Solutions, particularly with the transformative development initiatives Devana will be delivering to the industry in 2023.”

“Devana Solutions’ began as a tool for clinical research sites where it will remain the gold standard for research site productivity. The flexibility of the platform and the talent of the team also position Devana to be a Solution poised to unify what is a very disjointed industry.”

Founded in 2017, Velocity has grown dramatically in the last few years and now comprises 30 research sites across the United States with current global expansion underway. The Velocity model represents a new approach to site management. By owning and operating all sites directly, the organization offers a robust infrastructure that completely integrates the sites with singular systems and processes. Their model has proven to provide consistent and predictable patient recruitment and engagement. From a systems perspective, Velocity is an extremely technology-enabled organization, and under Koch’s direction, the Devana Solutions platform lies at the heart of Velocity’s business development, feasibility, and pre-award workflows, and both trial enrollment and overall business performance analytics.

According to Lake, “Craig’s expertise in leveraging our technology and industry insights will be a strong addition to Devana’s Advisory Board and our company. I look forward to his contributions.”

About Devana Solutions

Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions’ innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials. https://devanasolutions.com/

About Velocity Clinical Research

Velocity Clinical Research, headquartered in Durham, NC, is the leading integrated site organization for clinical trials, offering dedicated site capabilities to help biopharmaceutical and contract research organization customers find the right patients for their studies. Velocity supports global drug development in primarily conducting phase II and phase III clinical trials. The company has 30 U.S. locations across 14 states. Velocity places the care of the patient at the heart of everything we do. With over 35 years of experience running sites and more than 7,000 studies completed, Velocity has refined its patient recruitment strategies while maintaining a focus on delivering timely and reliable data quality. For more information. visit our website at https://velocityclinical.com.

About Us | IGNITE | Partner Spotlight | PROPEL

Devana Solutions Connects Research Operations and Business Intelligence at Scale with Clinical Conductor Integration

March 10, 2022 by

A new interface between Devana’s IGNITE and PROPEL products and Advarra’s Cloud-Based Clinical Trial Management System establishes an end-to-end solution for efficient research conduct and world-class business intelligence.

CHAPEL HILL, NC (March 10, 2022) – Devana Solutions is pleased to announce a new, at scale CTMS- integration solution for research organizations utilizing Advarra’s Clinical Conductor Clinical Trial Management System (CTMS), improving efficiency, and providing research sites with actionable insights across their entire research portfolio.

The Devana <-> Advarra integration is a dynamic, bi-directional data and process flow between Devana’s IGNITE and PROPEL products, and Advarra’s industry-leading Clinical Conductor CTMS. Following the natural progression of a trial, the trial startup begins in Devana, flows through Clinical Conductor for clinical execution and research operations management, and then back to Devana for end-to-end business intelligence. Enrollment performance metrics are derived automatically and pulled into the Devana system as research teams are interacting with Clinical Conductor, reducing duplicative workflows within the systems.

The robust and sought-after analytics, available within the Devana systems, offer configurable views to analyze performance data, by trial or indication, by site, or organization-wide. Combined with Clinical Conductor’s ability to optimize operational finances, regulatory compliance, and overall operational workflows, these integrated products provide a seamless, comprehensive, clinical research solution. After a very thorough and thoughtful technical approach, the Devana <-> Advarra CTMS integration is now live for all Clinical Conductor customers.

“At Devana Solutions, we have always prided ourselves in listening to our clients and being attentive to their needs,” explained Barry Lake, Devana Solutions’ CEO. “So, when the leadership at highly-valued client-partners, Javara Research and Velocity Clinical Research, encouraged an API-integration with Advarra’s Clinical Conductor CTMS to better support their study teams, we were eager to explore it.”

“We were pleased to work closely with the team at Advarra and the integration of both systems has increased our clients’ operational efficiency. We look forward to deploying the connection for the benefit of additional mutual clients. Working together, as an industry, we can and will move mountains!” added Lake.

“We are thrilled to collaborate with Devana and our customers on this innovative interface,” said James Wurdeman, Chief Product Officer at Advarra. “Devana’s approach to developing this integration aligns with our philosophy of creating site-centric, open, customer-focused technology solutions that can be integrated with enterprise systems across a research site or site network.”

Devana Solutions now boasts integrations with several leading CTMS technologies on the market. These integrations speak to more than just added convenience and increased efficiencies; they’re speeding up the clinical trial process resulting in improved clinical outcomes and therapies to patients.

About Devana Solutions

Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials. https://devanasolutions.com/

About Advarra

Advarra makes clinical research safer, smarter, and faster. Our integrated solutions help safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance for over 3,500 sponsors, CROs, institutions, academic medical centers, and research consortia.

With trusted and unequaled independent oversight committee services, innovative software solutions for sites, sponsors, and CROs, and experienced consultants with deep-seated connections across the industry, Advarra has the expertise and technology needed to advance clinical research and help our clients make the world a healthier place.

Headquartered in Columbia, Maryland, Advarra’s extensive geographic reach helps clients navigate the evolving research and regulatory environment. https://www.advarra.com/

1 2 3 4